Neoadjuvant pembrolizumab outperforms adjuvant pembrolizumab in resectable stage III–IV melanomas Presented ByDr Sapna Patel, MD Anderson Cancer Center, TX, USA TrialPhase 2, SWOG S1808 ConferenceESMO 2022 16 November, 2022 18:26